Frontline Treatment of Acute Myeloid Leukemia - Episode 8

Treatment of Patients Unfit for Intensive Induction with Venetoclax + Azacitidine

,

Hetty Carraway, MD, highlights the role of venetoclax + azacitidine in the treatment of patients with acute myeloid leukemia who are unfit for intensive induction therapy.